FFM
TMO icon

Fullerton Fund Management’s Thermo Fisher Scientific TMO Stock Holding History

Fullerton Fund Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,521
Closed -$6.7M – 121
2025
Q2 		$6.7M Sell
16,521
-3,326
-17% -$1.39M 0.27% 39
2025
Q1 		$9.88M Sell
19,847
-5,203
-21% -$2.82M 0.63% 36
2024
Q4 		$13M Sell
25,050
-51,777
-67% -$28.5M 0.46% 37
2024
Q3 		$47.5M Buy
76,827
+62,704
+444% +$37.1M 2% 16
2024
Q2 		$7.81M Sell
14,123
-20,069
-59% -$11.5M 0.35% 38
2024
Q1 		$19.9M Sell
34,192
-7,695
-18% -$4.32M 0.94% 24
2023
Q4 		$22.2M Sell
41,887
-12,882
-24% -$6.24M 1.29% 21
2023
Q3 		$27.7M Buy
54,769
+3,961
+8% +$2.11M 1.94% 17
2023
Q2 		$26.5M Buy
50,808
+3,529
+7% +$1.9M 1.85% 18
2023
Q1 		$27.3M Buy
47,279
+1,817
+4% +$1.02M 2.07% 16
2022
Q4 		$25M Sell
45,462
-35,563
-44% -$18.8M 1.86% 22
2022
Q3 		$41.1M Buy
81,025
+11,151
+16% +$6.24M 3.06% 15
2022
Q2 		$38M Sell
69,874
-12,319
-15% -$6.78M 2.52% 17
2022
Q1 		$48.5M Sell
82,193
-40,618
-33% -$23.3M 2.57% 14
2021
Q4 		$81.9M Buy
122,811
+26,859
+28% +$16.8M 4.11% 7
2021
Q3 		$54.8M Buy
+95,952
New +$52.7M 3.33% 8
2021
Q1 		– Sell
-33,802
Closed -$15.7M – 90
2020
Q4 		$15.7M Buy
33,802
+16,495
+95% +$7.73M 1.16% 32
2020
Q3 		$7.64M Buy
17,307
+5,206
+43% +$2.15M 1.02% 25
2020
Q2 		$4.38M Hold
12,101
– – 0.8% 26
2020
Q1 		$3.43M Buy
12,101
+4,319
+55% +$1.36M 0.65% 18
2019
Q4 		$2.53M Buy
+7,782
New +$2.36M 0.53% 25

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fullerton Fund Management's TMO Position: Q3 2025 in Review

Fullerton Fund Management sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 16,521 shares — an estimated $6.7M sold.

Fullerton Fund Management first reported a position in TMO in Q4 2019 and held it in 21 quarters. The position peaked at $81.9M in Q4 2021. 2,515 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Fullerton Fund Management reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Fullerton Fund Management sold 16,521 Thermo Fisher Scientific shares in Q3 2025, an estimated $6.7M.
  • Fullerton Fund Management first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 21 quarters.
  • Fullerton Fund Management's Thermo Fisher Scientific position peaked at $81.9M in Q4 2021.
  • 2,515 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Fullerton Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.